Every recall we track for Akorn, Inc. — 192 in all — plus the complaints and injury reports the public filed about them.
Akorn recalls Timolol Maleate Ophthalmic Solution 0.5% in various bottle sizes due to inability to perform stability studies after the company went out of business.
Akorn recalls 0.005% Calcipot: Scalp Solution 60mL bottles due to CGMP deviations after firm went out of business. No remedy provided in official notice.
Akorn recalls all 10mL Midazolam Injection vials due to stability study discontinuation after company closure. No remedy provided in official notice.
Akorn recalls 5% lidocaine ointment tubes due to stability concerns after manufacturer went out of business. All products are affected.
Akorn recalls all Granisetron HCl injection vials due to stability concerns after the company ceased operations. No remedy specified in official notice.
Akorn recalls Fluticasone Propionate Nasal Spray 50mcg 16g bottles due to stability concerns after manufacturer closure. All units affected.
Akorn recalls Gonak Hypromellose Ophthalmic Solution 25mg/mL 15mL bottles due to inability to conduct stability studies after the company went out of business.
Akorn recalls all Olopat: 665 mcg nasal spray bottles due to company closure halting stability testing. No remedy provided in official notice.
Akorn recalls 300 mg/5mL Oxcarbazepine Oral Suspension bottles due to stability concerns after the manufacturer closed. All units are affected; no remedy specified.
Akorn recalls 15mL piloc:1% ophthalmic solution bottles due to stability concerns after manufacturer went out of business. No remedy provided.
Akorn recalls all Albuterol Sulfate Syrup bottles due to stability concerns after the manufacturer ceased operations. This affects prescription-only products distributed by Akorn Operating Company.
Akorn recalls all Calcitriol Injection 2 mcg/mL ampules due to stability concerns after the manufacturer ceased operations. No remedy provided in official notice.
Akorn recalls all DOCU LIQUID (docusate sodium) bottles and cups due to stability concerns after the manufacturer ceased operations. No remedy provided in official notice.
Akorn recalls all 15mL Acetic Acid Otic Solution bottles (Rx only) due to company closure preventing stability testing. No remedy provided in official notice.
Akorn recalls Neomycin and Polymyxin B Sulfates ointment tubes because the manufacturer went out of business and can no longer ensure product stability.
Akorn recalls 0.5% Tropic: Stability studies halted due to company bankruptcy. All 15mL bottles with NDCs are affected. No remedy provided.
Akorn recalls all Acyclovir Oral Suspension (200mg/5mL) due to stability concerns after the manufacturer closed. This prescription medication may not be safe for long-term use.
Akorn recalls all Sufenta 50 mcg/mL injections (1mL, 2mL, 5mL ampules) due to inability to conduct stability studies after the company went out of business.
Akorn recalls all Lactulose Solution bottles due to company closure halting stability testing. No immediate risk but products may degrade over time.
Akorn recalls 0.05% Clobetasol Propionate Shampoo bottles due to CGMP deviations after firm went out of business. No remedy provided in official notice.
Akorn recalls all Ketorol: 0.5% ophthalmic solution bottles due to stability study discontinuation after company went out of business.
Akorn recalls all 2mg/5mL oral solution bottles due to inability to conduct stability studies after company went out of business.
Akorn recalls Prometh: 6.25 mg/5mL oral solution bottles due to stability problems after company went out of business. All units affected.
Akorn recalls 0.5% Proparacaine HCl Ophthalmic Solution 15mL bottles (Rx only) because the manufacturer went out of business and can't continue stability testing.
Akorn recalls DetomiSed (detomidine hydrochlor: 5mL and 20mL vials. All lots affected due to CGMP deviations after manufacturer went out of business.
Akorn recalls all 0.5% moxifloxacin eye drops due to stability concerns after the manufacturer closed. No remedy provided; affected users should check NDCs and lots.
Akorn recalls all 30mL single-dose ropivacaine injection vials due to company closure preventing stability testing. This affects prescription-only medical use.
Akorn recalls all Prometh: 6.25mg/10mg per 5mL oral solutions due to stability concerns after manufacturer went out of business.
Akorn recalls all Sodium DIURIL (chlorothiazide sodium) 0.5g vials due to inability to conduct stability studies after the manufacturer went out of business.
Akorn recalls 150mg Rifampin capsules due to stability concerns after the manufacturer closed. All lots and NDCs are affected. No remedy provided in official notice.
Akorn recalls all 400 IU cherry-flavored vitamin D drops due to company closure preventing stability testing. No immediate risk but products should be discarded.
Akorn recalls 4% pilocarpine eye drops (15mL) because the manufacturer went out of business and can't continue stability testing. All products are affected.
Akorn recalls XOPENEX inhalation solution due to stability concerns after firm went out of business. All units are affected; no remedy provided.
Akorn recalls all hydromorphone injections due to company closure halting stability testing. This affects all lots and NDCs. Consumers should contact the manufacturer for details.
Akorn recalls all 237mL Cimetidine HCl Oral Solution bottles due to stability problems after the manufacturer went out of business.
Akorn recalls all Lactulose Solution 30mL unit dose cups due to inability to complete stability studies after going out of business. This affects all units sold.
Akorn recalls 0.1% ophthalmic solution bottles due to inability to conduct stability studies after company closure. No remedy provided; affected products include all lots and NDCs.
Akorn recalls all Lorazepam Oral Concentrate 2mg/mL 30mL bottles due to stability concerns after the manufacturer closed. No remedy provided in official notice.
Akorn recalls cherry-flavored sulfamethoxazole and trimethoprim oral suspension due to inability to conduct stability studies after going out of business.
Akorn recalls 10mL hydrocortisone and acetic acid otic solution due to stability concerns after firm went out of business. All products are affected.
Akorn recalls all Guaiatussin AC Sugar-Free products due to company closure preventing stability testing. This may affect product safety and effectiveness.
Akorn recalls HydrALAZINE HCl injection vials due to inability to conduct stability studies after the company went out of business. All units are affected. No remedy specified in official notice.
Akorn recalls Cetrorelix Acetate injections due to manufacturer closure preventing stability testing. All units are affected. No remedy specified in official notice.
Akorn recalls 15mL 5% Sodium Chloride Ophthalmic Solution bottles due to inability to conduct stability studies after firm went out of business. All products are affected.
Akorn recalls all Levetiracetam Oral Solution 100 mg/mL (473mL) due to discontinued stability testing after the company went out of business.
Akorn recalls 2% Lidocaine HCl Jelly USP 5mL tubes due to stability concerns after the manufacturer closed. All products are affected. No remedy provided.
Akorn recalls all Lidocaine Hydrochloride Oral Topical Solution 2% 100mL tubes (Rx only) because the manufacturer went out of business and can no longer ensure product stability.
Akorn recalls acetaminophen and codeine phosphate oral solution due to CGMP deviations after the company went out of business. All products are affected.
Akorn recalls all 0.5% Apraclonidine Ophthalmic Solution bottles due to inability to conduct stability studies after the company went out of business.
Akorn recalls all Guaifenesin Oral Solution (30:15mL, sugar-free, alcohol-free) for institutional use due to company closure preventing stability testing.
Akorn recalls all Tobramycin Ophthalmic Solution 0.3% 5mL bottles due to stability concerns after manufacturer went out of business. No remedy provided in official notice.
Akorn recalls all Tobramycin Inhalation Solution USP 30:00 mg/5mL ampules due to inability to conduct stability studies after firm went out of business.
Akorn recalls 250mg/5mL Valproic Acid Oral Solution bottles due to stability concerns after manufacturer went out of business. All units are affected.
Akorn recalls 15 mg/5 mL prednisolone oral solution in 240mL and 480mL bottles due to stability concerns after the company went out of business. All lots and NDCs affected.
Akorn recalls all Fentanyl Citrate Injection products due to inability to complete stability studies after the company went out of business.
Akorn recalls all Diuril (chlorothiazide sodium) injections due to stability problems after the manufacturer ceased operations. No remedy provided; affected patients should contact their doctor.
Akorn recalls 20 mg/2 mL dicyclomine hydrochloride injection ampules due to inability to conduct stability studies after firm went out of business.
Akorn recalls levofloxacin oral solution bottles due to CGMP deviations after firm went out of business. All sizes and lots affected. No remedy provided.
Akorn recalls 2% piloc: 15mL eye drops (Rx only) because the manufacturer went out of business and can't do stability testing. No action needed as it's a prescription product.
